Tara Bancroft
Stock Analyst at TD Cowen
(4.85)
# 394
Out of 4,974 analysts
296
Total ratings
54.9%
Success rate
29.5%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Tara Bancroft
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| RCUS Arcus Biosciences | Initiated: Buy | n/a | $24.32 | - | 1 | Sep 16, 2026 | |
| FTH Faeth Therapeutics | Initiated Coverage: Buy | n/a | $35.37 | - | 1 | Sep 9, 2026 | |
| EYPT EyePoint | Downgraded: Hold | $20 → $4 | $3.66 | +9.29% | 4 | Sep 2, 2026 | |
| CELC Celcuity | Reiterated: Buy | n/a | $82.70 | - | 14 | Aug 13, 2026 | |
| FATE Fate Therapeutics | Reiterated: Hold | n/a | $2.35 | - | 14 | Aug 13, 2026 | |
| MGNX MacroGenics | Reiterated: Hold | n/a | $4.04 | - | 15 | Aug 13, 2026 | |
| STRO Sutro Biopharma | Reiterated: Buy | n/a | $16.56 | - | 13 | Aug 12, 2026 | |
| TCRX TScan Therapeutics | Reiterated: Buy | n/a | $0.3213 | - | 12 | Aug 12, 2026 | |
| VALN Valneva SE | Initiated Coverage: Buy | $12 | $6.54 | +83.49% | 1 | Aug 11, 2026 | |
| RCKT Rocket Pharmaceuticals | Reiterated: Hold | n/a | $3.41 | - | 3 | Aug 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $4.09 | - | 13 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $3 | $1.31 | +129.01% | 20 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $75 | $59.21 | +26.67% | 16 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $155 | $143.40 | +8.09% | 17 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $50 → $60 | $41.74 | +43.75% | 24 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $23.75 | - | 13 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $110 → $103 | $100.73 | +1.76% | 21 | Aug 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $20 | $10.19 | +96.27% | 24 | Aug 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $75 | $53.04 | +41.40% | 14 | Aug 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $3.67 | - | 13 | Jul 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $67.30 | - | 14 | Jul 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | n/a | $3.20 | - | 1 | Jun 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $28.91 | - | 2 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $35.38 | - | 3 | Apr 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $20.00 | $16.81 | +18.98% | 16 | Feb 19, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $1.30 | n/a | 2 | Mar 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | n/a | $4.98 | n/a | 3 | Aug 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $18.80 | n/a | 2 | Jul 26, 2024 |
Arcus Biosciences
Sep 16, 2026
Initiated: Buy
Price Target: n/a
Current: $24.32
Upside: -
Faeth Therapeutics
Sep 9, 2026
Initiated Coverage: Buy
Price Target: n/a
Current: $35.37
Upside: -
EyePoint
Sep 2, 2026
Downgraded: Hold
Price Target: $20 → $4
Current: $3.66
Upside: +9.29%
Celcuity
Aug 13, 2026
Reiterated: Buy
Price Target: n/a
Current: $82.70
Upside: -
Fate Therapeutics
Aug 13, 2026
Reiterated: Hold
Price Target: n/a
Current: $2.35
Upside: -
MacroGenics
Aug 13, 2026
Reiterated: Hold
Price Target: n/a
Current: $4.04
Upside: -
Sutro Biopharma
Aug 12, 2026
Reiterated: Buy
Price Target: n/a
Current: $16.56
Upside: -
TScan Therapeutics
Aug 12, 2026
Reiterated: Buy
Price Target: n/a
Current: $0.3213
Upside: -
Valneva SE
Aug 11, 2026
Initiated Coverage: Buy
Price Target: $12
Current: $6.54
Upside: +83.49%
Rocket Pharmaceuticals
Aug 10, 2026
Reiterated: Hold
Price Target: n/a
Current: $3.41
Upside: -
Aug 6, 2026
Reiterated: Hold
Price Target: n/a
Current: $4.09
Upside: -
Aug 5, 2026
Rated: Buy
Price Target: $3
Current: $1.31
Upside: +129.01%
Aug 5, 2026
Reiterated: Buy
Price Target: $75
Current: $59.21
Upside: +26.67%
Aug 5, 2026
Reiterated: Buy
Price Target: $155
Current: $143.40
Upside: +8.09%
Aug 5, 2026
Rated: Buy
Price Target: $50 → $60
Current: $41.74
Upside: +43.75%
Aug 5, 2026
Reiterated: Buy
Price Target: n/a
Current: $23.75
Upside: -
Aug 3, 2026
Downgraded: Hold
Price Target: $110 → $103
Current: $100.73
Upside: +1.76%
Aug 3, 2026
Reiterated: Buy
Price Target: $20
Current: $10.19
Upside: +96.27%
Aug 3, 2026
Reiterated: Buy
Price Target: $75
Current: $53.04
Upside: +41.40%
Jul 30, 2026
Reiterated: Buy
Price Target: n/a
Current: $3.67
Upside: -
Jul 30, 2026
Reiterated: Buy
Price Target: n/a
Current: $67.30
Upside: -
Jun 15, 2026
Initiated Coverage: Buy
Price Target: n/a
Current: $3.20
Upside: -
May 6, 2026
Reiterated: Buy
Price Target: n/a
Current: $28.91
Upside: -
Apr 1, 2026
Reiterated: Buy
Price Target: n/a
Current: $35.38
Upside: -
Feb 19, 2026
Reiterated: Buy
Price Target: $20.00
Current: $16.81
Upside: +18.98%
Mar 14, 2025
Rated: Hold
Price Target: n/a
Current: $1.30
Upside: n/a
Aug 9, 2024
Rated: Buy
Price Target: n/a
Current: $4.98
Upside: n/a
Jul 26, 2024
Downgraded: Hold
Price Target: n/a
Current: $18.80
Upside: n/a